Edwards Lifesciences Corp. has signed a $100m deal to acquire CAS Medical Systems Inc., the developer of a non-invasive technology for measuring tissue oxygenation in the brain.
Under the terms of the agreement, Edwards will pay $2.45 per share of CAS’ common stock, a 56% premium to...